NCT04760678View on ClinicalTrials.gov

Febrile Illness in Kinshasa and Kimpese

CompletedOBSERVATIONAL
Enrollment

1,046

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 18, 2023

Study Completion Date

September 18, 2023

Conditions
Febrile Illness
Interventions
OTHER

Observational study

No intervention (observational study in human participants)

Trial Locations (2)

Unknown

IME Kimpese, Kimpese

Hôpital General de Kinshasa, Kinshasa

All Listed Sponsors
collaborator

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT04760678 - Febrile Illness in Kinshasa and Kimpese | Biotech Hunter | Biotech Hunter